MX9302210A - Nuevos derivados de arilpiperidina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen - Google Patents
Nuevos derivados de arilpiperidina, procedimiento para su preparacion y composiciones farmaceuticas que los contienenInfo
- Publication number
- MX9302210A MX9302210A MX9302210A MX9302210A MX9302210A MX 9302210 A MX9302210 A MX 9302210A MX 9302210 A MX9302210 A MX 9302210A MX 9302210 A MX9302210 A MX 9302210A MX 9302210 A MX9302210 A MX 9302210A
- Authority
- MX
- Mexico
- Prior art keywords
- new
- arilpiperidine
- derivatives
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a la 1-(2-(2-naftil)-etil)-4-(3-trifluorometilfenil)pip eridina y a sus sales de adición de ácidos, útiles en el tratamiento del disfuncionamiento sexual en los mamíferos. El nuevo compuesto puede ser preparado por ejemplo por hidrogenación catalítica del derivado 1,2,3,6, tetrahidropiridínico correspondiente.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9204821A FR2690158B1 (fr) | 1992-04-17 | 1992-04-17 | Nouveau derive arylpiperidinique, procede pour sa preparation et compositions pharmaceutiques le contenant. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9302210A true MX9302210A (es) | 1993-10-01 |
Family
ID=9429039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9302210A MX9302210A (es) | 1992-04-17 | 1993-04-16 | Nuevos derivados de arilpiperidina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen |
Country Status (10)
Country | Link |
---|---|
US (1) | US5286734A (es) |
EP (1) | EP0566484A1 (es) |
JP (1) | JPH0625166A (es) |
KR (1) | KR930021617A (es) |
AU (1) | AU661387B2 (es) |
CA (1) | CA2094164A1 (es) |
FR (1) | FR2690158B1 (es) |
HU (2) | HUT70181A (es) |
MX (1) | MX9302210A (es) |
NO (1) | NO179172C (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2681931C2 (ru) * | 2017-08-01 | 2019-03-14 | Фарид Шамилевич Шагиахметов | Фармацевтическая комбинация для лечения алкогольной зависимости |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3910930A (en) * | 1973-01-04 | 1975-10-07 | Janssen Pharmaceutica Nv | 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones |
CA1173037A (en) * | 1980-03-01 | 1984-08-21 | John L. Archibald | Piperidino ureas as antidepressants |
GB2083476B (en) * | 1980-09-12 | 1984-02-08 | Wyeth John & Brother Ltd | Heterocyclic compounds |
FR2531707A1 (fr) * | 1982-08-16 | 1984-02-17 | Midy Spa | Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques |
US4921863A (en) * | 1988-02-17 | 1990-05-01 | Eisai Co., Ltd. | Cyclic amine derivatives |
FR2639226B1 (fr) * | 1988-11-18 | 1993-11-05 | Sanofi | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs |
WO1990006303A1 (en) * | 1988-12-02 | 1990-06-14 | Pfizer Inc. | Arylpiperidine derivatives |
FR2650505B1 (fr) * | 1989-08-07 | 1994-06-03 | Midy Spa | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale |
FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
FR2662442A1 (fr) * | 1990-05-23 | 1991-11-29 | Midy Spa | Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant. |
-
1992
- 1992-04-17 FR FR9204821A patent/FR2690158B1/fr not_active Expired - Fee Related
-
1993
- 1993-04-14 EP EP93400968A patent/EP0566484A1/fr not_active Ceased
- 1993-04-16 CA CA002094164A patent/CA2094164A1/en not_active Abandoned
- 1993-04-16 AU AU36953/93A patent/AU661387B2/en not_active Ceased
- 1993-04-16 US US08/049,106 patent/US5286734A/en not_active Expired - Fee Related
- 1993-04-16 HU HU9301115A patent/HUT70181A/hu unknown
- 1993-04-16 NO NO931420A patent/NO179172C/no unknown
- 1993-04-16 MX MX9302210A patent/MX9302210A/es unknown
- 1993-04-17 KR KR1019930006510A patent/KR930021617A/ko not_active Application Discontinuation
- 1993-04-19 JP JP5091657A patent/JPH0625166A/ja active Pending
-
1995
- 1995-06-29 HU HU95P/P00557P patent/HU211842A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
AU3695393A (en) | 1993-10-21 |
KR930021617A (ko) | 1993-11-22 |
HU9301115D0 (en) | 1993-07-28 |
JPH0625166A (ja) | 1994-02-01 |
NO931420D0 (no) | 1993-04-16 |
CA2094164A1 (en) | 1993-10-18 |
FR2690158B1 (fr) | 1994-07-22 |
NO931420L (no) | 1993-10-18 |
AU661387B2 (en) | 1995-07-20 |
HU211842A9 (en) | 1995-12-28 |
US5286734A (en) | 1994-02-15 |
NO179172B (no) | 1996-05-13 |
EP0566484A1 (fr) | 1993-10-20 |
HUT70181A (en) | 1995-09-28 |
FR2690158A1 (fr) | 1993-10-22 |
NO179172C (no) | 1996-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2158778B1 (es) | Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen. | |
ES2058527T3 (es) | Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen. | |
ES2053508T3 (es) | Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos. | |
AR002705A1 (es) | Un nuevo compuesto de indolina, un proceso para su preparacion y composiciones farmaceuticas que lo contienen. | |
AR021844A1 (es) | Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion | |
PL314188A1 (en) | Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions | |
ES2185307T3 (es) | Inhibidores de la farnesil transferasa que tienen una estructura piperidinica y procedimiento para su preparacion. | |
ES2179353T3 (es) | Antagonistas muscarinicos. | |
MX9300786A (es) | Compuestos hipolipidaemicos. | |
BRPI0406717A (pt) | Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção | |
ES2061848T3 (es) | Compuestos triciclos, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden. | |
AR003966A1 (es) | Un derivado de difenilmetilenpiperidina, composición farmacéutica que lo contiene, metodo de preparación de dicho derivado y uso de este ultimo para preparar un medicamento | |
MX9300616A (es) | Compuestos antagonistas del receptor 5-hidroxitriptamina, proceso para su prepararcion y composicion farmaceutica que los contiene | |
NO307688B1 (no) | Anvendelse av terfenadinderivater som antihistaminmidler i et farmasøytisk preparat | |
CA2216664A1 (fr) | Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
AR013462A1 (es) | Nuevos peptidomimeticos para el tratamiento de trastornos oseos, metodos para su produccion y drogas que contienen estos compuestos | |
AR008621A1 (es) | Un compuesto derivado de amina succinica, un procedimiento para llevar a cabo su preparacion y una composicion farmaceutica que comprende dichocompuesto | |
ES2043863T3 (es) | Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina. | |
ES2071666T3 (es) | Derivados de pirazoloisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
MX9401080A (es) | Compuestos heteroaromaticos. | |
AR005102A1 (es) | Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento. | |
MX9304424A (es) | Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
MX9302210A (es) | Nuevos derivados de arilpiperidina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
BG105794A (en) | (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions contaning the same | |
HUP0103113A2 (hu) | NOS inhibitorokat tartalmazó gyógyászati készítmények |